Comparison Chart Zentiva S.A.

Equities

End-of-day quote Bucharest S.E. Other stock markets 18:00:00 2024-05-13 EDT			5-day change	1st Jan Change
3.18 ^RON	-2.45%		-2.45%	+8.90%

04-01	Biocon Limited, Through Zentiva, Receives Approval from, U.K., for its Complex Formulation Liraglutide (gSaxenda®) in 6mg/ml Solution	CI
02-29	Zentiva S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	ZENTIVA S.A.	Generic Pharmaceuticals	-2.45%	-2.45%	+8.90%	+59.00%	-35.23%	493M	-	-	-